Literature DB >> 18033631

The diagnosis of late life hypogonadism.

John E Morley1.   

Abstract

The diagnosis of late life hypogonadism is controversial. For the purposes of discussion, it is suggested that treatment of late life hypogonadism requires the presence of symptoms, a low level of circulating free or bioavailable testosterone level and a positive response to treatment. While this may appear to be a radical proposal, we believe it represents the most rigorous scientific approach to the diagnosis of late life hypogonadism at the present time.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18033631     DOI： 10.1080/13685530701695463

Source DB:  PubMed          Journal:  Aging Male        ISSN： 1368-5538            Impact factor:   5.892


  4 in total

Review 1.  Diagnosis and management of testosterone deficiency syndrome in men: clinical practice guideline.

Authors:  Alvaro Morales; Richard A Bebb; Priya Manjoo; Peter Assimakopoulos; John Axler; Christine Collier; Stacy Elliott; Larry Goldenberg; Irv Gottesman; Ethan D Grober; Gordon H Guyatt; Daniel T Holmes; Jay C Lee
Journal:  CMAJ       Date:  2015-10-26       Impact factor: 8.262

Review 2.  Sarcopenia: diagnosis and treatment.

Authors:  J E Morley
Journal:  J Nutr Health Aging       Date:  2008 Aug-Sep       Impact factor: 4.075

Review 3.  Androgens are fundamental in the maintenance of male sexual health.

Authors:  Alvaro Morales
Journal:  Curr Urol Rep       Date:  2011-12       Impact factor: 3.092

4.  The relationship of serum and salivary cortisol levels to male sexual dysfunction as measured by the International Index of Erectile Function.

Authors:  Y Kobori; E Koh; K Sugimoto; K Izumi; K Narimoto; Y Maeda; H Konaka; A Mizokami; T Matsushita; T Iwamoto; M Namiki
Journal:  Int J Impot Res       Date:  2009-05-07       Impact factor: 2.896
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.